[1]
“Bioanalytical Method Validation and Bioequivalence Study of Ibrutinib in Human Plasma Using LC-MS/MS: An Advanced Approach”, pubs bcnf, vol. 2, no. 6, Jan. 2025, Accessed: Jan. 31, 2026. [Online]. Available: https://pubs.bcnf.ir/index.php/Articles/article/view/335